Please click here to view this emailer online
HHM Global Nedwsletter
Power Info Today Linkedin Page Power Info Today Facebook Page Power Info Today Twitter Page Weekly Newsletter
Click here to subscribe to our newsletter
Thailand lab international 2017
Top Latest Press Releases
FDA approves Thero fisher first companion diagnostic test

FDA approves first companion diagnostic test to screen multiple non-small cell lung cancer therapies

The U.S. FDA has granted premarket approval to Thermo Fisher Scientific for the first NGS -based test that simultaneously screens tumor samples for biomarkers associated with three FDA-approved therapies for non-small cell lung cancer (NSCLC).

READ MORE

PerkinElmer to Acquire EUROIMMUN Medical Laboratory Diagnostics AG

PerkinElmer, Inc announced that it has entered into a definitive agreement to acquire EUROIMMUN Medical Laboratory Diagnostics AG. The agreement provides that PerkinElmer will acquire up to a 100% stake in EUROIMMUN.

READ MORE

Swedish healthcare provider selects Sectras digital pathology solution for diagnostics Systems

International medical imaging IT and cybersecurity company Sectra announces that Vasternorrland County Council, in Sweden, orders Sectra solution for storing and reviewing digital pathology images.

READ MORE
Articles
The right climate conditions for the NICU

The right climate conditions for the NICU

Babies are warm and cozy in the amniotic sac where they can float nearly weightlessly. External stimuli are cushioned, and the tiny body only perceives them slightly. A mother womb cannot be replaced. Medical technology has, however, advanced continuously...

READ MORE


Modernizing Medicine Announces Agreement With Covermymeds For Electronic Prior Authorization

CoverMyMeds, a leader in electronic prior authorization (ePA) solutions, and Modernizing Medicine, the specialty-specific health IT leader, announced an agreement to bring electronic prior...

READ MORE

Janssen Biotech announces US FDA approval of DARZALEX

Janssen Biotech, Inc. announced that the U.S. FDA has approved the immunotherapy DARZALEX (daratumumab) in combination with pomalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least...

READ MORE

Advertising:

sunnyroger@hhmglobal.com
Phone: + 91 84476 12124


For the latest visit: www.hhmglobal.com